Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peanuta non grata revisited.

Literature DB >> 31514786

Peanuta non grata revisited.

Joseph A Bellanti, Russell A Settipane.

Abstract

Mesh：

Year: 2019 PMID： 31514786 PMCID： PMC6715857 DOI： 10.2500/aap.2019.40.4245

Source DB: PubMed Journal: Allergy Asthma Proc ISSN： 1088-5412 Impact factor: 2.587

Keyword Cloud
References

× No keyword cloud information.

27 in total

1. Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Authors: Karsten Weller; Marcus Maurer; Moshe Fridman; Dylan Supina; Jennifer Schranz; Markus Magerl
Journal: Allergy Asthma Proc Date: 2017-01-16 Impact factor: 2.587

Review 2. New and evolving therapies for hereditary angioedema.

Authors: Sara Barmettler; Yu Li; Aleena Banerji
Journal: Allergy Asthma Proc Date: 2019-01-01 Impact factor: 2.587

3. Hereditary angioneurotic edema … a disease has been described.

Authors: Joseph A Bellanti; Russell A Settipane
Journal: Allergy Asthma Proc Date: 2017-11-01 Impact factor: 2.587

4. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.

Authors: H Henry Li; Avner Reshef; James W Baker; Joseph R Harper; Anurag Relan
Journal: Allergy Asthma Proc Date: 2017-09-05 Impact factor: 2.587

5. Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study.

Authors: Abhishek Kavati; Maryia Zhdanava; Benjamin Ortiz; Jason LeCocq; Bradd Schiffman; Dominic Pilon; Hoi Ching Cheung; Patrick Lefebvre; Brian D Stone
Journal: Allergy Asthma Proc Date: 2019-07-25 Impact factor: 2.587

6. Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures.

Authors: Toan Do; Ethan Canty; Puneet Bajaj; Faoud Ishmael; Timothy Craig
Journal: Allergy Asthma Proc Date: 2019-09-01 Impact factor: 2.587

Peanuta non grata revisited.

1. Health-related quality of life with hereditary angioedema following prophylaxis with subcutaneous C1-inhibitor with recombinant hyaluronidase.

Review 2. New and evolving therapies for hereditary angioedema.

3. Hereditary angioneurotic edema … a disease has been described.

4. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.

5. Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study.

6. Long-term assessment of aspirin desensitization shows successful bridging with non-aspirin nonsteroidal anti-inflammatory drugs for procedures.

7. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.

8. Practical peanut challenges for the clinician.

9. Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.

10. Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial.